8 early application of high cut-off haemodyalisis for de-novo myeloma nephropathy is associated with long-term dialysis-independency and renal recovery

9 Neoadjuvant chemoradiation for adenocarcinoma of the pancreas

10 Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial

11 Design, synthesis, and biological activity of TLR7-based compounds for chemotherapy-induced alopecia.

12 NOLAN: a randomized, phase 2 study to estimate the effect of prophylactic naproxen or loratadine vs no prophylactic treatment on bone pain in patients with early-stage breast cancer receiving chemotherapy and pegfilgrastim

13 Effects of cognitive behavioral therapy on psychological adjustment in Chinese pediatric cancer patients receiving chemotherapy: A randomized trial.

14 Predictive proteomic signatures for response of pancreatic cancer patients receiving chemotherapy.

15 Bacterial bloodstream infections and antimicrobial susceptibility pattern in pediatric hematology/oncology patients after anticancer chemotherapy

16 A Rare Case of Grey Zone Lymphoma Successfully Treated with Brentuximab Vedotin and R-CHP Chemotherapy

17 Efficacy of Neoadjuvant Chemotherapy with Capecitabine plus Oxaliplatin in the Treatment of Locally Advanced Sigmoid Colon Cancer Invading the Urinary Bladder: A Report of Three Cases

18 The Value of Intravoxel Incoherent Motion (IVIM) Magnetic Resonance Imaging in the Evaluation of the Osteosarcoma Response to Preoperative Neoadjuvant Chemotherapy in Teens

19 Bacterial bloodstream infections and antimicrobial susceptibility pattern in pediatric hematology/oncology patients after anticancer chemotherapy

20 Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: long-term results of a phase III multicentre randomised controlled trial.

21 Mesenchymal stem cells preserve their stem cell traits after exposure to antimetabolite chemotherapy.

22 Intravoxel incoherent motion (IVIM) for response assessment in patients with osteosarcoma undergoing neoadjuvant chemotherapy.

23 The Experience of Chemotherapy Teaching and Readability of Chemotherapy Educational Materials for Women with Breast Cancer.

24 DF2726A, a new IL-8 signalling inhibitor, is able to counteract chemotherapy-induced neuropathic pain

25 Temperature/pH-Triggered PNIPAM-Based Smart Nanogel System Loaded With Anastrozole Delivery for Application in Cancer Chemotherapy.

26 Cancer, chemotherapy, and HIV: Living with cancer amidst comorbidity in a South African township.

27 Essential human resources for antimicrobial stewardship teams in Japan: Estimates from a nationwide survey conducted by the Japanese Society of Chemotherapy

28 A phase III randomised clinical trial of perioperative therapy (neoadjuvant chemotherapy versus chemoradiotherapy) in locally advanced gallbladder cancers (POLCAGB): study protocol.

29 Impact of Chemotherapy on Symptoms and Symptom Clusters in Postmenopausal Women with Breast Cancer Prior to Aromatase Inhibitor Therapy.

30 Development of synthetic high-density lipoprotein-based ApoA-I mimetic peptide-loaded docetaxel as a drug delivery nanocarrier for breast cancer chemotherapy.

31 Home-Based yoga program for the patients suffering from malignant lymphoma during chemotherapy: A feasibility study

32 Sustained release paclitaxel-loaded core-shell-structured solid lipid microparticles for intraperitoneal chemotherapy of ovarian cancer

33 Serum microRNA-21 predicted treatment outcome and survival in HER2-positive breast cancer patients receiving neoadjuvant chemotherapy combined with trastuzumab.

34 Ambulatory Toxicity Management (AToM) in patients receiving adjuvant or neo-adjuvant chemotherapy for early stage breast cancer - a pragmatic cluster randomized trial protocol.

35 Effect of acupoint therapies on chemotherapy-induced nausea and vomiting: A systematic review protocol.

36 Oral Complications in Children Undergoing Chemotherapy: The COMEDY (Clenching, Oral Mucositis, Eyes, DYsphagia) Pattern.

37 Effects of weight loss and sarcopenia on response to chemotherapy, quality of life, and survival.

38 The association between social support and chemotherapy-related toxicity in older patients with cancer.

39 Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis.

40 Body image, social support, effects of chemotherapy, and sexual desire in breast cancer patients

41 Direct-to-implant breast reconstruction after neoadjuvant chemotherapy: A safe option?

42 Outcome and feasibility of palliative chemotherapy in very elderly patients with metastatic breast cancer.

43 Cyclic dipeptide nanoribbons formed by dye-mediated hydrophobic self-assembly for cancer chemotherapy.

44 Impact of a chemotherapy workload and productivity dashboard on pharmacy technician turnover.

45 Photon buildup factors of some chemotherapy drugs.

46 Human factors product design for a prototype of hair loss prevention machine for cancer patients during chemotherapy treatments

47 Barriers and facilitators to chemotherapy patients' engagement in medical error prevention

48 Towards an open-source oncology electronic medical records system for low-resource settings: Development of chemotherapy management in OpenMRS

49 Adjuvant chemotherapy in colorectal cancer: mournful, hopeful perpetual motion machine heads to dim light at end of tunnel.

50 Adjuvant Chemotherapy in Colorectal Cancer: Mournful, Hopeful Perpetual Motion Machine Heads to Dim Light at End of Tunnel

51 CDA and MTHFR polymorphisms are associated with clinical outcomes in gastroenteric cancer patients treated with capecitabine-based chemotherapy

52 Gene expression of , , , and topoisomerase IIα as an indicator of chemotherapy response in AML treated with cytarabine and daunorubicin.

53 Gene expression of hENT1, dCK, CDA, dCMPD and topoisomerase IIα as an indicator of chemotherapy response in AML treated with cytarabine and daunorubicin

54 Comparative Effectiveness of Chemotherapy, Rituximab, and Bendamustine in Medicare Beneficiaries With Mantle-Cell Lymphoma.

55 Association of Early-Stage Breast Cancer and Subsequent Chemotherapy With Risk of Atrial Fibrillation.

56 Prevention and Treatment of Chemotherapy and Radiotherapy Induced Oral Mucositis.

57 Intraperitoneal Chemotherapy: A Strategy for the Treatment of Refractory Ascites in Recurrent Endometrial Cancer Patients - Three Case Reports and Review of the Literature.

58 A molecular sub-cluster of colon cancer cells with low VDR expression is sensitive to chemotherapy, BRAF inhibitors and PI3K-mTOR inhibitors treatment.

59 Vancomycin-resistance gene cluster, vanC, in the gut microbiome of acute leukemia patients undergoing intensive chemotherapy.

60 Procalcitonin and C-Reactive Protein As Markers of Bacteremia in Patients With Febrile Neutropenia Who Receive Chemotherapy for Acute Leukemia: A Prospective Study From Nepal.

61 Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomised, open-label, phase 3 trial.

62 Folic acid decorated metal-organic frameworks loaded with doxorubicin for tumor-targeted chemotherapy of osteosarcoma.

63 Doxorubicin chemotherapy affects the intracellular and interstitial free amino acid pools in skeletal muscle.

64 Co-delivery of erlotinib and doxorubicin by MoS2 nanosheets for synergetic photothermal chemotherapy of cancer

65 Numerical modeling of high-intensity focused ultrasound-mediated intraperitoneal delivery of thermosensitive liposomal doxorubicin for cancer chemotherapy

66 Doxorubicin/cisplatin co-loaded hyaluronic acid/chitosan-based nanoparticles for in vitro synergistic combination chemotherapy of breast cancer

67 Lymphocyte-monocyte ratio at day 14 of first cisplatin-doxorubicin chemotherapy is associated with treatment outcome of pediatric patients with localized osteosarcoma

68 [10-Years experience in the chemotherapy of pulmonary tuberculosis at the Medizinischen Universitatsklinik Freiburg].

69 Vaccination of cancer patients treated with chemotherapy: A survey among general practitioners.

70 Development and validation of a novel MR imaging predictor of response to induction chemotherapy in locoregionally advanced nasopharyngeal cancer: a randomized controlled trial substudy (NCT01245959).

71 PICC-PORT totally implantable vascular access device in breast cancer patients undergoing chemotherapy.

72 Temporal validation of metabolic nodal response of esophageal cancer to neoadjuvant chemotherapy as an independent predictor of unresectable disease, survival, and recurrence

73 Capecitabine versus S-1 as adjuvant chemotherapy for patients with stage III colorectal cancer (JCOG0910): an open-label, non-inferiority, randomised, phase 3, multicentre trial.

74 The roles of surgery and EMA/CO chemotherapy regimen in primary refractory and non-refractory gestational trophoblastic neoplasia.

75 Hepatocyte growth factor enhances the clearance of a multidrug-resistant Mycobacterium tuberculosis strain by high doses of conventional chemotherapy, preserving liver function

76 Palliative chemotherapy in head and neck cancer: balancing between beneficial and adverse effects.

77 Kanglaite injection plus platinum-based chemotherapy for stage III/IV non-small cell lung cancer: A meta-analysis of 27 RCTs.

78 Does delayed initiation of adjuvant chemotherapy following the curative resection affect the survival outcome of gastric cancer patients: A systematic review and meta-analysis.

79 Ambulatory Toxicity Management (AToM) Pilot: results of a pilot study of a pro-active, telephone-based intervention to improve toxicity management during chemotherapy for breast cancer

80 The Japanese herbal medicine Hangeshashinto enhances oral keratinocyte migration to facilitate healing of chemotherapy-induced oral ulcerative mucositis.

81 Response monitoring of breast cancer patients receiving neoadjuvant chemotherapy using quantitative ultrasound, texture, and molecular features

82 Induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma

83 Development and preliminary testing of a brief clinical tool to enable daily monitoring of chemotherapy toxicity: The Daily Chemotherapy Toxicity self-Assessment Questionnaire.

84 Prognostic Value and Implication for Chemotherapy Treatment of ABCB1 in Epithelial Ovarian Cancer: A Meta-Analysis.

85 Biodegradable organosilica magnetic micelles for magnetically targeted MRI and GSH-triggered tumor chemotherapy.

86 Formal consensus method to evaluate the conformity of prescription of a recently approved chemotherapy treatment in an observatory study.

87 Markers of early cardiotoxicity in patients with breast cancer undergoing chemotherapy depending on blood pressure level

88 Re: Safety and Outcomes of New Generation Hormone-Therapy in Elderly Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer Patients in the Real World

89 Long-term outcomes with intensive induction chemotherapy (carboplatin, bleomycin, vincristine and cisplatin/bleomycin, etoposide and cisplatin) and standard bleomycin, etoposide and cisplatin in poor prognosis germ cell tumours: A randomised phase II trial (ISRCTN53643604).

90 Initiation of adjuvant chemotherapy and trastuzumab for human epidermal growth receptor 2-positive early invasive breast cancer in a population-based cohort study of older women in England.

91 Phase II study assessing the effectiveness of Biafine cream as a prophylactic agent for radiation-induced acute skin toxicity to the breast in women undergoing radiotherapy with concomitant CMF chemotherapy.

92 Sense of coherence and acceptance of the disease in patients with lung cancer during palliative chemotherapy.

93 Therapeutic potential of medicinal plants indicated by the Brazilian public health system in treating the collateral effects induced by chemotherapy, radiotherapy, and chemoradiotherapy: A systematic review

94 Prognostic value of tumor-infiltrating lymphocyte subtypes in residual tumors of patients with triple-negative breast cancer after neoadjuvant chemotherapy.

95 Prognostic Factors in HER2-Positive Primary Breast Cancer Patients Treated Using Neoadjuvant Chemotherapy Plus Trastuzumab

96 Loxapine for Treatment of Patients With Refractory, Chemotherapy-Induced Neuropathic Pain: A Prematurely Terminated Pilot Study Showing Efficacy But Limited Tolerability.

97 Is Adjuvant Chemotherapy Necessary for Patients with Deficient Mismatch Repair Gastric Cancer?-Autophagy Inhibition Matches the Mismatched.

98 Prevention of chemotherapy-induced nausea and vomiting with acupuncture: A protocol for systematic review and meta-analysis.

99 Auditory function and quality of life in patients receiving cisplatin chemotherapy in head and neck cancer: A case series follow-up study.

100 Volumetric Assessment of Unaffected Parenchyma and Wilms' Tumors: Analysis of response to Chemotherapy and Surgery using a Semi-Automated Segmentation Algorithm in Children with Renal Neoplasms.

101 The Informational, Psychological and Social Needs of Patients Undergoing Chemotherapy, Visiting Imam Reza Teaching Hospital, Tabriz, in 2016

Keyword Connections

Journals

Research Groups

Bibliographies